Jacob P. Thyssen

Jun 25, 2024 | onlinelibrary.wiley.com | Alexander Egeberg |Jacob P. Thyssen

In 1952, topical hydrocortisone proved effective in reducing severity of atopic dermatitis (AD). The use of topical corticosteroids (TCS) has since become widespread, and it is today used widely to treat acute and chronic inflammatory skin diseases.

Jun 15, 2023 | onlinelibrary.wiley.com | Andreas Wollenberg |Jacob P. Thyssen |Thomas Bieber |Gary C Chan

SHORT REPORT This article has been accepted for publication and undergone full peer review but has not been through the copyediting, typesetting, pagination and proofreading process, which may lead to differences between this version and the Version of Record. Please cite this article as doi:10.1111/jdv.19255.

May 31, 2023 | futuremedicine.com | Kristian Reich |Jacob P. Thyssen |Andrew Blauvelt |Kilian Eyerich

ImmunotherapyAhead of PrintPlain Language Summary of PublicationOpen Access, , , , , , , , , , , , , , & AbstractWhat is this summary about? Atopic dermatitis (AD, also called atopic eczema) is a skin disease that that can affect a person for a long time and causes red or flaky skin that can be itchy and uncomfortable.

Apr 24, 2023 | healio.com | Richard Gawel |Kristen Dowd |Benjamin Ungar |Jacob P. Thyssen

Source/Disclosures Disclosures: Thyssen reports having advisory roles with AbbVie, Almirall, Arena Pharmaceuticals, Aslan Pharmaceuticals, Coloplast, Eli Lilly & Co., LEO Pharma, OM Pharma, Pfizer, Regeneron, Sanofi-Genzyme and Union Therapeutics; having speaker roles with AbbVie, Almirall, Eli Lilly & Co., LEO Pharma, Pfizer, Regeneron and Sanofi-Genzyme; and receiving research grants from Pfizer, Regeneron and Sanofi-Genzyme.

Feb 3, 2023 | thelancet.com | Alexander Egeberg |Jacob P. Thyssen

Hidradenitis suppurativa is a chronic inflammatory skin disease affecting the hair follicles that reside in axillary, inguinal, and submammary folds.